Position
BRAIDWELL LP in CG Oncology, Inc.
Back to the book · All holders of CGON
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $25.8M$41.52 → $67.68
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.87M | $77.7M | — | — | — | 2.5% |
| Q1 2026 | 984.8K | $66.7M | $67.68 | $25.8M | −$36.8M | 2.2% |